+Compare
SIBN
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
852.58M

SIBN SI-BONE Forecast, Technical & Fundamental Analysis

a sacroiliac joint medical device company

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for SIBN with price predictions
08:00 PM EDT Sep 21, 2023

Momentum Indicator for SIBN turns positive, indicating new upward trend

SIBN saw its Momentum Indicator move above the 0 level on September 21, 2023. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 85 similar instances where the indicator turned positive. In of the 85 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where SIBN's RSI Oscillator exited the oversold zone, of 21 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Moving Average Convergence Divergence (MACD) for SIBN just turned positive on August 23, 2023. Looking at past instances where SIBN's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SIBN advanced for three days, in of 309 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 223 cases where SIBN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SIBN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SIBN broke above its upper Bollinger Band on August 30, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.805) is normal, around the industry mean (24.959). P/E Ratio (0.000) is within average values for comparable stocks, (79.268). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.238). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (6.042) is also within normal values, averaging (58.582).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SIBN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SIBN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Intuitive Surgical (NASDAQ:ISRG), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Align Technology (NASDAQ:ALGN), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.32B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was -4%. For the same Industry, the average monthly price growth was -7%, and the average quarterly price growth was -7%. AVGR experienced the highest price growth at 135%, while HSCS experienced the biggest fall at -48%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was -40%. For the same stocks of the Industry, the average monthly volume growth was 0% and the average quarterly volume growth was 38%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 71
Price Growth Rating: 66
SMR Rating: 83
Profit Risk Rating: 88
Seasonality Score: -23 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I. Advisor
published Earnings

SIBN is expected to report earnings to rise 16.27% to -34 cents per share on November 06

SI-BONE SIBN Stock Earnings Reports
Q3'23
Est.
$-0.35
Q2'23
Beat
by $0.10
Q1'23
Beat
by $0.09
Q4'22
Beat
by $0.08
Q3'22
Beat
by $0.06
The last earnings report on August 07 showed earnings per share of -30 cents, beating the estimate of -40 cents. With 227.09K shares outstanding, the current market capitalization sits at 852.58M.
A.I. Advisor
published General Information

General Information

a sacroiliac joint medical device company

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
471 El Camino Real
Phone
+1 408 207-0700
Employees
357
Web
http://www.si-bone.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRITX17.520.04
+0.23%
T. Rowe Price International Stock
GOFIX23.290.01
+0.04%
GMO Resources III
POIRX14.11N/A
N/A
Polen International Growth Investor
CDCRX11.10-0.02
-0.18%
Copeland Dividend Growth Fund Class C
TASMX27.69-0.12
-0.43%
Transamerica Small/Mid Cap Value R6

SIBN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SIBN has been loosely correlated with NSTG. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if SIBN jumps, then NSTG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIBN
1D Price
Change %
SIBN100%
-0.28%
NSTG - SIBN
50%
Loosely correlated
+4.17%
BVS - SIBN
47%
Loosely correlated
+0.69%
ATEC - SIBN
40%
Loosely correlated
+2.82%
ZBH - SIBN
39%
Loosely correlated
-0.81%
GH - SIBN
39%
Loosely correlated
-0.69%
More

Groups containing SIBN

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIBN
1D Price
Change %
SIBN100%
-0.28%
medical research
(undefined stocks)
44%
Loosely correlated
-1.02%
medical service
(undefined stocks)
41%
Loosely correlated
-1.17%
Medical Specialties
(undefined stocks)
41%
Loosely correlated
-0.72%
Medical Specialties
(undefined stocks)
41%
Loosely correlated
-0.72%
medical devices
(undefined stocks)
36%
Loosely correlated
+0.14%